OFS
DGX icon

OneAscent Financial Services’s Quest Diagnostics DGX Stock Holding History

OneAscent Financial Services’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$276K Sell
1,300
-23
-2% -$4.51K 0.01% 510
2026
Q1 		$259K Buy
+1,323
New +$257K 0.01% 502
2025
Q4 		– Sell
-1,139
Closed -$217K – 477
2025
Q3 		$217K Sell
1,139
-196
-15% -$34.8K 0.01% 463
2025
Q2 		$240K Sell
1,335
-177
-12% -$30.7K 0.02% 472
2025
Q1 		$256K Sell
1,512
-65
-4% -$10.7K 0.02% 426
2024
Q4 		$238K Buy
+1,577
New +$245K 0.02% 415

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

OneAscent Financial Services's DGX Position: Q2 2026 in Review

OneAscent Financial Services reduced its Quest Diagnostics (DGX) stake by 1.7% in Q2 2026, selling an estimated $4.51K and leaving 1,300 shares worth $276K. The position accounts for 0.01% of the portfolio, ranked #510.

OneAscent Financial Services first reported a position in DGX in Q4 2024 and has held it in 6 quarters since. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • OneAscent Financial Services held 1,300 shares of Quest Diagnostics worth $276K as of Q2 2026.
  • OneAscent Financial Services sold 23 Quest Diagnostics shares in Q2 2026, an estimated $4.51K.
  • Quest Diagnostics made up 0.01% of OneAscent Financial Services's portfolio in Q2 2026, its #510 holding.
  • OneAscent Financial Services first reported a position in Quest Diagnostics in Q4 2024 and has held it in 6 quarters since.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on OneAscent Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.